3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Carcinoma, Non-Small-Cell Lung
2
Thrombocytosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Mantle-Cell
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inhibition, Psychological
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
B-cell Malignancies
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
pembrolizumab
45
Paclitaxel
42
Carboplatin
34
Bevacizumab
18
Specimen Handling
17
Letrozole
16
lenvatinib
13
Magnetic Resonance Spectroscopy
12
dostarlimab
11
Cisplatin
11
Biopsy
11
Taxes
10
olaparib
9
Fulvestrant
9
Doxorubicin
9
abemaciclib
8
Megestrol Acetate
8
Docetaxel
8
durvalumab
7
atezolizumab
7
Nivolumab
7
Gemcitabine
7
Blood Specimen Collection
7
palbociclib
6
Oxaliplatin
6
Observation
6
Fluorouracil
6
niraparib
5
Surveys and Questionnaires
5
Progestins
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
INCB039110
×
1 year
×
Clear all
No trials found.